Roche Holding AG RHHVF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 76.83B | 76.37B | 74.21B | 72.52B | 71.13B |
| Total Other Revenue | 2.55B | 2.41B | 2.22B | 2.20B | 2.19B |
| Total Revenue | 79.38B | 78.78B | 76.43B | 74.73B | 73.32B |
| Cost of Revenue | 20.50B | 20.23B | 19.53B | 18.97B | 18.48B |
| Gross Profit | 58.88B | 58.55B | 56.90B | 55.76B | 54.84B |
| SG&A Expenses | 17.16B | 17.08B | 16.64B | 16.25B | 15.94B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -57.72M | -57.28M | -45.55M | 119.35M | 288.38M |
| Total Operating Expenses | 53.09B | 52.73B | 51.25B | 50.47B | 49.90B |
| Operating Income | 26.29B | 26.05B | 25.18B | 24.26B | 23.42B |
| Income Before Tax | 20.64B | 20.77B | 20.38B | 17.79B | 15.24B |
| Income Tax Expenses | 3.87B | 3.89B | 3.81B | 3.54B | 3.28B |
| Earnings from Continuing Operations | 16.77K | 16.88K | 16.57K | 14.25K | 11.96K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.20B | -1.17B | -1.11B | -1.07B | -1.03B |
| Net Income | 15.57B | 15.72B | 15.46B | 13.18B | 10.93B |
| EBIT | 26.29B | 26.05B | 25.18B | 24.26B | 23.42B |
| EBITDA | 30.21B | 29.92B | 28.90B | 27.93B | 27.06B |
| EPS Basic | 19.56 | 19.74 | 19.42 | 16.56 | 13.73 |
| Normalized Basic EPS | 17.81 | 17.73 | 17.20 | 16.58 | 16.02 |
| EPS Diluted | 19.35 | 19.55 | 19.25 | 16.41 | 13.61 |
| Normalized Diluted EPS | 17.61 | 17.55 | 17.05 | 16.44 | 15.90 |
| Average Basic Shares Outstanding | 3.18B | 3.18B | 3.18B | 3.19B | 3.19B |
| Average Diluted Shares Outstanding | 3.22B | 3.22B | 3.21B | 3.21B | 3.21B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 63.66% | 61.48% | 58.14% | 68.17% | 82.22% |